# Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer

> **NCT00116155** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cell Genesys**

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** CV787 (CG7870)

## Key facts

- **NCT ID:** NCT00116155
- **Lead sponsor:** Cell Genesys
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116155, "Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00116155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*